Items tagged with Drug-resistant TB
Advocates call on Indian government to improve its response to drug-resistant TB (post with simple image)
Advocates call for minimizing the use of injectable agents and scaling up universal drug susceptibility testing.
WHO updates its treatment guidelines for MDR/RR-TB (post with simple image)
The updated WHO treatment guidelines recommend that drug-resistant TB be treated with oral drugs only, including newer, more potent drugs with fewer side effects.
TB activists for first time challenge TB drug patent in India (post with simple image)
TB activists for first time challenge TB drug patent in India, in bid to prevent Johnson & Johnson from extending monopoly.
TB CAB statement on safety of using bedaquiline and delamanid together (post with simple image)
Global TB CAB welcomes confirmation of safety of using bedaquiline and delamanid together, urges uptake.
TAG statement on FDA priority review of pretomanid (post with simple image)
Statement from Treatment Action Group on FDA priority peview of TB Alliance’s new anti-TB drug pretomanid.
New WHO recommendations to accelerate progress on TB (post with simple image)
WHO issues new guidance to improve treatment of multidrug-resistant TB.
Advocates raise serious concerns about errors in the WHO guidelines for the treatment of drug-resistant TB (post with simple image)
Advocates call on WHO leadership to act immediately and correct specific technical errors in the WHO guidelines for the treatment of drug-resistant TB.
MSF: Johnson & Johnson should make TB drug available for all at $1/day (post with simple image)
MSF protests at J&J’s annual shareholders meeting to demand a say in how lifesaving TB drug developed with considerable joint efforts, including public funding and MSF operational research, will be made available and affordable.
Ad-hoc donations of bedaquiline threaten sustainable, affordable access for patients (post with simple image)
Advocates call on Indian Minister of Health to discontinue and phase out the drug donations of bedaquiline offered by Johnson & Johnson.
It’s Time to End Drug-Resistant Tuberculosis: The Case for Action (post with simple image)
The cost of complacency: Economist Intelligence Unit report underscores major gaps in world’s response to drug-resistant TB.
Page 89 of 92 · Total posts: 0←First 88 89 90 Last→